Accessibility Menu
Becton, Dickinson logo

Becton, Dickinson(NYSE) BDX

Market Cap$45.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1968)+20,925%
5 Year-8%
1 Year+21%
1 Month+8%
$166.22
+0.47%
+0.77Today
After hours$165.62-$0.60 (-0.36%)
Becton, Dickinson last closing stock price
MetricPriceDate
Last closeUSD 165.622026-07-31
Becton, Dickinson stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.92%USD 156.362026-07-24
1 month+8.32%USD 152.902026-07-01
3 month+11.71%USD 148.262026-05-01
Year to date+10.06%USD 150.482025-12-31
1 year+21.13%USD 136.722025-07-31
3 year-19.73%USD 206.332023-08-01
5 year-7.78%USD 179.602021-07-30
Since inception+20,925.19%USD 0.791968-01-02

Becton, Dickinson Financials at a Glance

Market Cap

$45.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$21.37B

Net Income (TTM)

$1.14B

EPS (TTM)

$3.94

P/E Ratio

41.95

Dividend

$4.19

Beta (Volatility)

0.48 (Low)

Price

$166.22

Volume

2,025,132

Open

$163.80

Previous Close

$165.62

Daily Range

$162.45 - $166.29

52-Week Range

$127.54 - $187.35

Estimated Earnings Date

Aug 6, 2026

BDX News

hypodermic needles syringe drug pharma

My Top Dividend Growth Stock to Buy in July and Hold Forever

Selena MaranjianJul 20, 2026
Doctor and patient talking.

Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom

Prosper Junior BakinyJul 7, 2026
dividend-kings-infographic

Dividend Kings of 2026

Matt DiLalloJul 2, 2026
Getty - strong powerful muscle biceps strength

The Healthcare Stock Built for Investors Who Prioritize Capital Preservation

Selena MaranjianApr 17, 2026
Copy of dividends blackboard sketch doodle

3 Magnificent Dividend Stocks the Sell-Off Has Put on Sale. Buy Them Now and Hold Forever.

Thomas NielApr 17, 2026
financial health stethoscope money cash hundred bills medical healthcare-1200x803-37403b6

What Makes a Healthcare Stock Worth Holding Through a Recession?

Thomas NielApr 14, 2026
Physicians in an operating room

Market Crash: The Healthcare Stocks I'd Buy Without Hesitation

Prosper Junior BakinyApr 10, 2026
25_12_29 A surgical robot _robotic surgery surgical equipment-1067x800-9f8a157

2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $1,000

Reuben Gregg BrewerMar 8, 2026
Page 1

BDX: Motley Fool Moneyball Superscore

64

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Becton, Dickinson

Becton Dickinson makes medical devices and lab tools used in hospitals and clinics. Its products help doctors deliver medicine, collect blood, and diagnose diseases. Everyday users benefit from safer injections and faster test results.

Gadgets, Needles, and More: What BD Sells

  • Medical Devices (53.1% of Q3 2025 revenue): Syringes, IV catheters, and drug delivery tools for hospitals and clinics.
  • Life Sciences (22.8%): Blood collection tubes, lab testing kits, and equipment for disease detection and research labs.
  • Interventional Products (24.1%): Surgical tools, hernia repair materials, and urology devices for operating rooms and specialty care.
  • Diabetes Care: Insulin syringes and pen needles for people managing diabetes at home or in clinics.
  • Automated Medication Systems: Machines that help hospitals safely store and track medicines.

BD’s Growth Spurt: Mergers, Moves, and Milestones

  • Acquired Advanced Patient Monitoring from Edwards Lifesciences in 2024 to expand hospital monitoring tools.
  • Announced combination of Biosciences and Diagnostic Solutions with Waters Corporation in July 2025, gaining a 39.2% stake and $4 billion cash.
  • Expanded into emerging markets, with 7.8% revenue growth in Q3 2025.
  • Invested in new product development and manufacturing upgrades to meet regulatory standards.
  • Entered new regions and upgraded supply chains to support global sales since 2024.

Why BD Stands Out in the Crowd

BD operates in over 50 countries, reaching hospitals and labs worldwide. Its broad product range and focus on process improvement help manage costs and meet changing regulations. The company’s scale and steady investment in research support its position in the medical device market.

Five Things You Need to Know

  • Revenue was $5.25 billion in Q1 2026, up 1.6% year-over-year.
  • Operating income reached $594 million in Q1 2026, up 31.1% year-over-year.
  • Net income was $382 million in Q1 2026, up 26.1% year-over-year.
  • Cash flow from operations was $657 million in Q1 2026, down 5.2% year-over-year.

Bottom Line

BD has grown through acquisitions, product innovation, and global expansion. Its diverse product lines and adaptability help it navigate a complex healthcare market.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

72,000

CEO

Thomas E. Polen, Jr., MBA

Website

www.bd.com

Headquarters

Franklin Lakes, NJ 07417-1880, US

BDX Financials

Key Financial Metrics (TTM)

Gross Margin

46.48%

Operating Margin

10.61%

Net Income Margin

5.33%

Return on Equity

4.54%

Return on Capital

5.78%

Return on Assets

2.24%

Earnings Yield

2.38%

Dividend Yield

2.26%

Payout Ratio

1.04%

Stock Overview

Market Cap

$45.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

275.54M

Volume

2.03M

Avg. Volume

2.67M

Financials (TTM)

Gross Profit

$9.93B

Operating Income

$2.27B

EBITDA

$4.68B

Operating Cash Flow

$3.90B

Capital Expenditure

-$759.00M

Free Cash Flow

$3.14B

Cash & ST Invst.

$816.00M

Total Debt

$17.28B

Becton, Dickinson Performance Analysis

Becton, Dickinson annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30USD 18,870,000,000-1.4%
20232023-09-30USD 19,372,000,0002.7%
20242024-09-30USD 20,178,000,0004.2%
20252025-09-30USD 21,840,000,0008.2%
Becton, Dickinson sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-304.5%
Q42025-09-306.9%
Q12025-12-31-10.8%
Q22026-03-31-10.2%
Becton, Dickinson annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30USD 5.88-14.2%
20232023-09-30USD 4.94-16.0%
20242024-09-30USD 5.8618.7%
20252025-09-30USD 5.82-0.7%
Becton, Dickinson sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-3086.9%
Q42025-09-30-14.0%
Q12025-12-31-22.1%
Q22026-03-31-182.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$4.71B

-10.6%

Gross Profit

$2.15B

-4.6%

Gross Margin

45.69%

N/A

Market Cap

$45.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$633.17K

N/A

Employees

72,000

N/A

Net Income

-$311.00M

-201.0%

EBITDA

$709.00M

-36.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$816.00M

+19.5%

Total Debt

$17.28B

-10.3%

Accounts Receivable

$2.21B

-27.2%

Inventory

$3.36B

-9.8%

Long Term Debt

$14.71B

-16.8%

Short Term Debt

$2.57B

+60.4%

Return on Assets

2.24%

N/A

Return on Invested Capital

5.36%

N/A

Free Cash Flow

$546.00M

+1460.0%

Operating Cash Flow

$671.00M

+309.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IDXXIDEXX Laboratories, Inc.
$559.07+0.05%
HLNHaleon plc
$9.87-2.37%
EWEdwards Lifesciences Corporation
$86.07-0.98%
AAgilent Technologies, Inc.
$138.37-0.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About BDX

What is the current price of Becton, Dickinson?

Becton, Dickinson is trading at $165.62 per share.

What is the 52-week range for Becton, Dickinson?

Over the past 52 weeks, Becton, Dickinson has traded between $127.54 and $187.35.

How much debt does Becton, Dickinson have?

As of the most recent reporting period, Becton, Dickinson reported total debt of $17.28B.

How much cash does Becton, Dickinson have on hand?

Becton, Dickinson reported $1.02B in cash and cash equivalents in its most recent financial results.

What is Becton, Dickinson’s dividend yield?

Becton, Dickinson currently has a dividend yield of 2.26%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services